T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Arista Networks
ANET
|
+$4.06B |
| 2 |
Oracle
ORCL
|
+$2.93B |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$2.35B |
| 4 |
Apple
AAPL
|
+$2.27B |
| 5 |
Caterpillar
CAT
|
+$2.12B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$3.44B |
| 2 |
Eli Lilly
LLY
|
+$2.51B |
| 3 |
Microsoft
MSFT
|
+$2.39B |
| 4 |
FISV
Fiserv Inc
FISV
|
+$2.2B |
| 5 |
Norfolk Southern
NSC
|
+$1.97B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 36.3% |
| 2 | Financials | 11.67% |
| 3 | Consumer Discretionary | 10.88% |
| 4 | Communication Services | 10.76% |
| 5 | Healthcare | 9.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
776
Beam Therapeutics
BEAM
$2.74B
| $54.9M | 0.01% |
2,263,149
-179,727
| -7% | -$3.58M |
|
777
Otis Worldwide
OTIS
$27.8B
| $54.9M | 0.01% |
599,957
-756,413
| -56% | -$68.7M |
|
778
NewMarket
NEU
$8.72B
| $54.8M | 0.01% |
66,192
+30,697
| +86% | +$23.6M |
|
779
Synchrony
SYF
$26.1B
| $54.8M | 0.01% |
770,978
-44,814
| -5% | -$3.25M |
|
780
Skyward Specialty Insurance
SKWD
$2.39B
| $54.7M | 0.01% |
1,150,243
+35,529
| +3% | +$1.78M |
|
|
FLY
781
Firefly Aerospace
FLY
$4.48B
| $54.6M | 0.01% |
+1,861,340
| New | +$83.7M |
|
782
H&R Block
HRB
$6.76B
| $54M | 0.01% |
1,066,857
+80,260
| +8% | +$4.24M |
|
783
Delta Air Lines
DAL
$60B
| $53.9M | 0.01% |
949,386
+255
| +0% | +$14.6K |
|
784
Alcoa
AA
$13.1B
| $53.9M | 0.01% |
1,637,671
+96,141
| +6% | +$2.99M |
|
785
Ferguson
FERG
$48B
| $53.6M | 0.01% |
238,800
-2,954,983
| -93% | -$669M |
|
786
Moelis & Co
MC
$5.21B
| $53.6M | 0.01% |
751,452
+694,320
| +1,215% | +$49.6M |
|
787
Prudential Financial
PRU
$43B
| $53.5M | 0.01% |
515,307
-2,876
| -0.6% | -$303K |
|
788
Merit Medical Systems
MMSI
$5.4B
| $53.3M | 0.01% |
640,847
-91,497
| -12% | -$7.97M |
|
789
uniQure
QURE
$3.26B
| $53.3M | 0.01% |
+913,180
| New | +$16.6M |
|
790
Northern Trust
NTRS
$34.8B
| $53.3M | 0.01% |
395,835
-8,008
| -2% | -$1.03M |
|
791
Praxis Precision Medicines
PRAX
$10.3B
| $53.2M | 0.01% |
1,003,490
-469,585
| -32% | -$22.8M |
|
792
On Holding
ONON
$10.6B
| $52.8M | 0.01% |
1,245,775
-364,019
| -23% | -$17.3M |
|
793
Medpace
MEDP
$16.2B
| $52.6M | 0.01% |
102,328
-976
| -0.9% | -$426K |
|
794
Xometry
XMTR
$5.42B
| $52.5M | 0.01% |
964,690
+916,216
| +1,890% | +$39.8M |
|
795
Cirrus Logic
CRUS
$6.08B
| $52.4M | 0.01% |
418,323
+11,171
| +3% | +$1.24M |
|
796
Viridian Therapeutics
VRDN
$2.49B
| $52.2M | 0.01% |
2,418,104
-477,161
| -16% | -$8.61M |
|
797
Woodward
WWD
$21.2B
| $52.1M | 0.01% |
206,204
-27,375
| -12% | -$6.8M |
|
798
Coherent
COHR
$64B
| $52M | 0.01% |
482,485
+296,203
| +159% | +$29.5M |
|
799
Axcelis
ACLS
$4.42B
| $52M | 0.01% |
532,108
+2,965
| +0.6% | +$239K |
|
800
Crane Co
CR
$12.7B
| $51.8M | 0.01% |
281,470
+2,832
| +1% | +$534K |
|
Similar funds
T. Rowe Price Associates's Q3 2025 Portfolio in Review
As of Q3 2025, T. Rowe Price Associates held 3,142 positions worth $935B, up 5.9% from $883B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
T. Rowe Price Associates's Q3 2025 filing shows 87 new, 2,049 increased, 682 reduced and 98 closed positions. Its largest new stake was Cemex: 19,009,088 shares worth $171M. The largest sale was Amazon, an estimated $3.44B.
By sector, the portfolio is most concentrated in Technology at 36% of assets, up from 35% a quarter earlier, followed by Financials and Consumer Discretionary.
- T. Rowe Price Associates's largest Q3 2025 buy was Cemex: 19,009,088 shares worth $171M.
- T. Rowe Price Associates added most to Arista Networks in Q3 2025, an estimated $4.06B increase.
- T. Rowe Price Associates's biggest Q3 2025 reduction was Amazon, cutting an estimated $3.44B.
- T. Rowe Price Associates fully exited Hess in Q3 2025, selling an estimated $308M.
- T. Rowe Price Associates's ten largest holdings make up 37% of its $935B portfolio in Q3 2025.
- T. Rowe Price Associates opened 87 new positions and closed 98 in Q3 2025.
- T. Rowe Price Associates's portfolio value rose 5.9% quarter-over-quarter to $935B.
Based on T. Rowe Price Associates's 13F filing for Q3 2025, filed 14 Nov 2025.